We collaborate with 7 comprehensive cancer centres in Czech Republic (Brno - Masaryk Memorial Cancer Institute, Prague, Olomouc, Ostrava, Plzen, Hradec Kralove, Zlin) with all legal agreements in place and a huge capacity in providing clinical specimens and patients clinical data enabling large prospective biomarkers studies.
We started collaboration with industry on development of CE IVD diagnostic kits for non-invasive early detection of colorectal cancer (circulating microRNAs and piRNAs) (BioVendor - Laboratorni medicina a.s.) and prediction of therapeutic response to anti-EGFR therapy in metastatic colorectal cancer with wild-type RAS (tissue microRNAs) (Generi-Biotech, Ltd.).
Prof. George Calin, MD, PhD, Anderson Cancer Center, TX, USA;
Prof. Vince Fischetti, PhD, Rockfeller University, NY, USA;
Prof. Massimo Negrini, MD, PhD, University of Ferrara, Ferrara, Italy;
Assoc. Prof. Martin Pichler, MD, PhD, Medical University of Graz, Austria;
Markus Kretz, PhD, University of Regensburg, Regensburg, Germany;
Prof. Klaus Jung, MD, PhD, University Hospital Charité, Humboldt University, Berlin, Germany.